圧迫療法の世界市場分析および予測

◆英語タイトル:MediPoint: Compression Therapy - Global Analysis and Market Forecasts
◆商品コード:GDME0216MAR
◆発行会社(調査会社):GlobalData
◆発行日:2015年10月1日
◆ページ数:279
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD6,495 ⇒換算¥662,490見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD12,990 ⇒換算¥1,324,980見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD16,995 ⇒換算¥1,733,490見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、圧迫療法の世界市場について調査・分析し、以下の構成でお届けいたします。

・イントロダクション
・圧迫療法産業概観
・アンメットニーズ分析
・圧迫療法の市場機会分析
・市場の成長要因および阻害要因
・競争分析
・圧迫療法の製品パイプライン分析
・圧迫療法の治験動向
・主要企業分析
・圧迫療法の世界市場規模予測
・圧迫療法の地域別市場規模予測
【レポートの概要】

MediPoint: Compression Therapy – Global Analysis and Market Forecasts

Summary

Compression therapy products, especially static compression devices, have become the standard in the treatment of venous conditions, such as deep vein thrombosis (DVT), varicose veins, and venous leg ulcers, and lymphatic disorders, such as primary and secondary lymphedema. While elastic stockings and compression bandaging have played important roles in providing effective therapies, newer modes of static compression such as custom garments and adjustable products have been introduced to ease patient burden and improve treatment compliance. Pneumatic compression devices have similarly advanced, despite their lower adoption rates. Segmented pumps with tunable pressure characteristics have joined the ranks of simpler devices with single outputs for single inflatable chambers in the treatment of venous and lymphatic conditions. Although pneumatic compression has not quite been an arena of rapid innovation, some manufacturers have developed advanced pump systems that deliver complex pressure profiles to the affected areas of the patients’ bodies. This report focuses on both static and pneumatic compression market categories. The overall compression therapy market has been estimated in this report, which covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India (10MM) up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of compression therapy in the 10MM.

Highlights

Key Questions Answered

- What is the current and future market outlook for compression therapy products in the developed and emerging markets? What trends are affecting the global compression therapy market?
- Which are the key, high growth markets? What compression therapy segments are growing the fastest?
- What are the unmet needs? What is the scope for more innovation and what are the end-users looking for in their products?
- What are some of the newer innovations that may fulfill these unmet needs? What are the physician perceptions and market outlooks?
- What percent of global revenue are from emerging markets? How will this change in the future?
- Sigvaris, BSN Medical, Medi, and Medtronic currently dominate the global advanced dressings market. What are their market shares in the major global economies and which companies constitute the remainder of the market?

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

【レポートの目次】

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 12
1.2 List of Figures 20
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 22
3 Industry Overview 23
3.1 Overview 23
3.2 Anatomy & Physiology 23
3.2.1 Chronic Venous Disease 23
3.2.2 Varicose Veins 24
3.2.3 Venous Leg Ulcers 25
3.2.4 Venous Thromboembolism and Deep Vein Thrombosis 25
3.2.5 Lymphedema 27
3.3 Clinical Outcomes 29
3.3.1 Venous Conditions 29
3.3.2 Lymphedema 29
3.4 Applications of Technology 30
3.4.1 Static Compression 30
3.4.2 Pneumatic Compression Devices 32
3.5 Advantages and Disadvantages of Technology 33
3.6 Market Access 34
3.7 Influence of Clinical Trials 36
3.8 Regulatory Process 36
3.8.1 Overview 36
3.8.2 United States 37
3.8.3 EU5 37
3.8.4 Japan 38
3.8.5 China 39
3.8.6 India 40
3.8.7 Brazil 40
3.9 Reimbursement 41
3.9.1 Overview 41
3.9.2 United States 42
3.9.3 France 44
3.9.4 Germany 45
3.9.5 Italy 46
3.9.6 Spain 47
3.9.7 UK 47
3.9.8 Japan 48
3.9.9 China 50
3.9.10 India 50
3.9.11 Brazil 50
3.10 Regulatory Issue & Key Deals 51
3.10.1 Regulatory Issues & Recalls 51
3.10.2 Mergers, Acquisitions, and Key Partnerships 52
3.11 Economic Impact 53
3.11.1 Indirect Costs 53
3.11.2 Direct Costs 54
4 Unmet Needs 55
4.1 Overview 55
4.2 Improving Patient Education 55
4.3 Implementing Consistent Bandaging 56
4.4 Expanding Caregiver Education 57
4.5 Enhancing Patient Comfort 57
4.6 Supporting Patient Mobility 58
5 Market Opportunity Analysis 60
5.1 Overview 60
5.2 Engineering Adjustable Garments for Greater Flexibility 60
5.3 Developing Multilayer Stockings for Easier Application 60
5.4 Improving Compression Garments by Adding Sensors 61
5.5 Innovating Automated Bandaging for Consistent Treatment 61
6 Market Drivers and Barriers 63
6.1 Drivers 63
6.1.1 Aging Populations 63
6.1.2 Cancer-Related Lymphedema 63
6.1.3 Rising Rates of Obesity 64
6.1.4 Lymphatic Filariasis in Underdeveloped Regions 64
6.1.5 The Need for Cost Savings 65
6.2 Barriers 65
6.2.1 Insufficient Reimbursement 65
6.2.2 Patient Compliance 66
6.2.3 Cost of Care 67
6.2.4 Medical Device Excise Tax 67
6.2.5 Availability of Venture Capital 68
6.3 Substitutes 68
6.3.1 Procedures to Prevent Thromboembolism 68
6.3.2 Invasive and Non-invasive Interventions for Varicose Veins 69
6.3.3 Surgical Interventions for Lymphedema 69
6.3.4 Pharmacological Options for DVT Management 70
7 Competitive Assessment 71
7.1 Overview 71
7.2 Technology and Product Offerings 71
7.3 Product Profile 71
7.3.1 Covidien (Medtronic) 71
7.3.2 Sigvaris 74
7.3.3 BSN Medical 76
7.3.4 Medi 78
7.3.5 Laboratoires Innothera 82
7.3.6 3M Health Care 84
7.3.7 Thuasne 85
7.3.8 Paul Hartmann 87
7.3.9 Mego Afek 89
7.3.10 Medline Industries 92
7.3.11 ArjoHuntleigh 93
7.3.12 DJO Global 95
7.3.13 Lohmann & Rauscher 97
7.3.14 Venosan (Salzmann) 101
7.3.15 Sanyleg 104
7.3.16 Juzo 105
7.3.17 Daesung Maref 107
7.3.18 Bio Compression Systems 108
7.3.19 Smith & Nephew 110
7.3.20 Molnlycke Health Care 112
7.3.21 Gloria Med 114
7.3.22 B. Braun 116
7.3.23 Alcare 117
7.3.24 Derma Sciences 118
7.3.25 Urgo 120
7.3.26 Systagenix 121
7.3.27 Muranaka Medical Instruments 121
7.3.28 ConvaTec 122
7.3.29 Xiamen Senyang 123
7.3.30 Guangzhou Yihao Electronic Technology 124
7.3.31 Talley Group 125
7.3.32 Cardinal Health 126
7.3.33 Tactile Medical 127
7.3.34 Devon Medical 129
7.4 SWOT For Each Category of Device 130
7.4.1 SWOT, Compression Garments 131
7.4.2 SWOT, Compression Bandages 132
7.4.3 SWOT, Anti-Embolism Stockings 133
7.4.4 SWOT, Pneumatic Compression Therapy 133
8 Pipeline Assessment 135
8.1 Overview 135
8.2 Product Profiles 135
8.2.1 Medical Compression Systems: ActiveCast and ActiveCare Vascular 135
8.2.2 Epoch Medical Systems: Adaptive Compression for Lower Limb Prosthetics 135
8.2.3 Footfalls & Heartbeats: Compression Bandage with Textile-based Sensor 136
9 Clinical Trials to Watch 137
9.1 Overview 137
9.2 Clinical Trial Profiles 137
9.2.1 Evaluation of a Dual Action Pneumatic Compression Device 137
9.2.2 Treatment Response to Different Lymphedema Compression Programs Using a Pneumatic Compression Device 137
9.2.3 Two Pneumatic Compression Devices for the Treatment of Lower Extremity Lymphedema 138
9.2.4 A Hemodynamic Comparison Study of Stationary and Portable Pneumatic Compression Devices 138
9.2.5 DVT Prevention Study: Geko Neurosmuscular Stimulator vs. Thromboembolism Deterrent Stockings (TEDS) 138
9.2.6 Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome 139
9.2.7 Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema 139
9.2.8 Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphedema 140
10 Current and Future Players 141
10.1 Overview 141
10.2 Company Profiles 141
10.2.1 Covidien (Medtronic) 141
10.2.2 Sigvaris 143
10.2.3 BSN Medical 145
10.2.4 Medi 146
10.2.5 Innothera 148
10.2.6 3M Health Care 149
10.2.7 Thuasne 150
10.2.8 Paul Hartmann 151
10.2.9 Mego Afek 153
10.2.10 Medline Industries 154
10.2.11 ArjoHuntleigh (Getinge) 156
10.2.12 DJO Global 158
10.2.13 Lohmann & Rauscher 160
10.2.14 Venosan (Salzmann) 161
10.2.15 Sanyleg (Mimosa) 162
10.2.16 Juzo 163
10.2.17 Daesung Maref 164
10.2.18 Bio Compression Systems 165
10.2.19 Smith & Nephew 166
10.2.20 Molnlycke Health Care 169
10.2.21 Gloria Med 170
10.2.22 B. Braun 171
10.2.23 Alcare 173
10.2.24 Derma Sciences 174
10.2.25 Laboratoires Urgo 176
10.2.26 Systagenix (Acelity) 178
10.2.27 Muranaka Medical Instruments 179
10.2.28 ConvaTec 180
10.2.29 Xiamen Senyang 182
10.2.30 Guangzhou Yihao Electronic Technology 183
10.2.31 Talley Group 184
10.2.32 Cardinal Health 185
10.2.33 Tactile Medical 186
10.2.34 Devon Medical 187
10.3 Other Current Players 189
11 Strategic Competitive Assessment 190
11.1 Company Market Share 190
11.1.1 Overview 190
11.1.2 Company Share by Region 190
12 Market Outlooks by Market Segment 197
12.1 Global Overview 197
12.2 By Region 199
12.2.1 5EU 199
12.2.2 APAC 201
13 Market Outlooks by Geography 203
13.1 Global Overview 203
13.2 By Region 207
13.2.1 5EU 207
13.2.2 APAC 208
13.3 US 209
13.4 France 212
13.5 Germany 215
13.6 Italy 217
13.7 Spain 220
13.8 UK 222
13.9 Japan 225
13.10 China 228
13.11 India 230
13.12 Brazil 233
14 Appendix 236
14.1 Bibliography 236
14.2 Abbreviations 269
14.3 Methodology 273
14.3.1 Overview 273
14.3.2 Coverage 273
14.3.3 Secondary Research 273
14.4 Forecasting Methodology 274
14.5 Physicians and Specialists Included in This Study 275
14.5.1 Key Opinion Leaders 275
14.5.2 Primary Research Summary 276
14.6 About the Authors 277
14.6.1 Shashank Settipalli, Analyst, Medical Devices 277
14.6.2 Priya Radhakrishnan, MBA, Director, Research and Analysis, Medical Devices 277
14.7 About GlobalData 278
14.8 Disclaimer 278

1.1 List of Tables
Table 1: The C Classification for Chronic Venous Conditions 24
Table 2: E, A, and P Classifications for Chronic Venous Conditions 24
Table 3: Stages of Lymphedema 27
Table 4: Sample HCPCS Codes for Compression Therapy Products 43
Table 5: Sample ICD-10 Codes for Indications That Require Compression Therapy 43
Table 6: Reimbursement Classification for Medical Devices in Japan 49
Table 7: Covidien’s Compression Therapy Marketed Products 72
Table 8: Covidien’s Compression Therapy Product Portfolio SWOT Analysis, 2015 73
Table 9: Sigvaris Compression Therapy Marketed Products 74
Table 10: Sigvaris’ Compression Therapy Product Portfolio SWOT Analysis, 2015 76
Table 11: BSN Medical’s Compression Therapy Marketed Products 77
Table 12: BSN Medical’s Compression Therapy Product Portfolio SWOT Analysis, 2015 78
Table 13: Medi Compression Therapy Marketed Products 79
Table 14: Medi’s Compression Therapy Product Portfolio SWOT Analysis, 2015 82
Table 15: Innothera’s Compression Therapy Marketed Products 83
Table 16: Laboratoires Innothera’s Compression Therapy Product Portfolio SWOT Analysis, 2015 83
Table 17: 3M Health Care’s Compression Therapy Marketed Products 84
Table 18: 3M Health Care’s Compression Therapy Product Portfolio SWOT Analysis, 2015 85
Table 19: Thuasne’s Compression Therapy Marketed Products 86
Table 20: Thuasne’s Compression Therapy Product Portfolio SWOT Analysis, 2015 87
Table 21: Paul Hartmann’s Compression Therapy Marketed Products 88
Table 22: Paul Hartmann Compression Therapy Product Portfolio SWOT Analysis, 2015 89
Table 23: Mego Afek’s Compression Therapy Marketed Products 90
Table 24: Mego Afek’s Compression Therapy Product Portfolio SWOT Analysis, 2015 91
Table 25: Medline’s Compression Therapy Marketed Products 92
Table 26: Medline Industries’ Compression Therapy Product Portfolio SWOT Analysis, 2015 93
Table 27: ArjoHuntleigh Compression Therapy Marketed Products 94
Table 28: ArjoHuntleigh’s Compression Therapy Product Portfolio SWOT Analysis, 2015 95
Table 29: DJO Global’s Compression Therapy Marketed Products 96
Table 30: DJO Global’s Compression Therapy Product Portfolio SWOT Analysis, 2015 97
Table 31: Lohmann & Rauscher’s Compression Therapy Marketed Products 98
Table 32: Lohmann & Rauscher’s Compression Therapy Product Portfolio SWOT Analysis, 2015 101
Table 33: Venosan’s Compression Therapy Marketed Products 102
Table 34: Venosan’s Compression Therapy Product Portfolio SWOT Analysis, 2015 103
Table 35: Sanyleg’s Compression Therapy Marketed Products 104
Table 36: Sanyleg’s Compression Therapy Product Portfolio SWOT Analysis, 2015 105
Table 37: Juzo’s Compression Therapy Marketed Products 106
Table 38: Juzo’s Compression Therapy Product Portfolio SWOT Analysis, 2015 107
Table 39: Daesung Maref’s Compression Therapy Marketed Products 107
Table 40: Daesung Maref’s Compression Therapy Product Portfolio SWOT Analysis, 2015 108
Table 41: Bio Compressions Systems Compression Therapy Marketed Products 109
Table 42: Bio Compression Systems’ Compression Therapy Product Portfolio SWOT Analysis, 2015 110
Table 43: Smith & Nephew’s Compression Therapy Marketed Products 111
Table 44: Smith & Nephew’s Compression Therapy Product Portfolio SWOT Analysis, 2015 112
Table 45: Molnlycke’s Health Care Compression Therapy Marketed Products 113
Table 46: Molnlycke’s Compression Therapy Product Portfolio SWOT Analysis, 2015 114
Table 47: Gloria Med’s Compression Therapy Marketed Products 115
Table 48: Gloria Med’s Compression Therapy Product Portfolio SWOT Analysis, 2015 116
Table 49: B. Braun Compression Therapy Marketed Products 116
Table 50: B. Braun’s Compression Therapy Product Portfolio SWOT Analysis, 2015 117
Table 51: Alcare’s Compression Therapy Marketed Products 117
Table 52: Alcare Compression Therapy Product Portfolio SWOT Analysis, 2015 118
Table 53: Derma Sciences’ Compression Therapy Marketed Products 118
Table 54: Derma Sciences’ Compression Therapy Product Portfolio SWOT Analysis, 2015 119
Table 55: Urgo’s Compression Therapy Marketed Products 120
Table 56: Urgo’s Compression Therapy Product Portfolio SWOT Analysis, 2015 120
Table 57: Systagenix’s Compression Therapy Marketed Products 121
Table 58: Systagenix’s Compression Therapy Product Portfolio SWOT Analysis, 2015 121
Table 59: Muranaka’s Medical Instruments Compression Therapy Marketed Products 122
Table 60: ConvaTec Compression Therapy Marketed Products 122
Table 61: ConvaTec’s Compression Therapy Product Portfolio SWOT Analysis, 2015 123
Table 62: Xiamen Senyang’s Compression Therapy Marketed Products 123
Table 63: Xiamen Senyang’s Compression Therapy Product Portfolio SWOT Analysis, 2015 124
Table 64: Guangzhou Yihao Electronic Technology Compression Therapy Marketed Products 124
Table 65: Guangzhou Yihao’s Compression Therapy Product Portfolio SWOT Analysis, 2015 125
Table 66: Talley Group Compression Therapy Marketed Products 125
Table 67: Talley Group’s Compression Therapy Product Portfolio SWOT Analysis, 2015 126
Table 68: Cardinal Health’s Compression Therapy Marketed Products 126
Table 69: Cardinal Health’s Compression Therapy Product Portfolio SWOT Analysis, 2015 127
Table 70: Tactile Medical’s Compression Therapy Marketed Products 127
Table 71: Tactile Medical’s Compression Therapy Product Portfolio SWOT Analysis, 2015 128
Table 72: Devon Medical’s Compression Therapy Marketed Products 129
Table 73: Devon Medical’s Compression Therapy Product Portfolio SWOT Analysis, 2015 130
Table 74: Compression Garments SWOT Analysis, 2015 131
Table 75: Compression Bandages SWOT Analysis, 2015 132
Table 76: Anti-Embolism Stockings SWOT Analysis, 2015 133
Table 77: Pneumatic Compression Therapy SWOT Analysis, 2015 133
Table 78: Covidien (Medtronic) Company Profile 142
Table 79: Covidien (Medtronic) SWOT Analysis, 2015 143
Table 80: Sigvaris Company Profile 144
Table 81: Sigvaris SWOT Analysis, 2015 145
Table 82: BSN Medical Company Profile 145
Table 83: BSN Medical SWOT Analysis, 2015 146
Table 84: Medi Company Profile 147
Table 85: Medi SWOT Analysis, 2015 147
Table 86: Innothera Company Profile 148
Table 87: Innothera SWOT Analysis, 2015 148
Table 88: 3M Company Profile 149
Table 89: 3M SWOT Analysis, 2015 150
Table 90: Thuasne Company Profile 151
Table 91: Thuasne SWOT Analysis, 2015 151
Table 92: Paul Hartmann Company Profile 152
Table 93: Paul Hartmann SWOT Analysis, 2015 153
Table 94: Mego Afek Company Profile 153
Table 95: Mego Afek SWOT Analysis, 2015 154
Table 96: Medline Company Profile 155
Table 97: Medline SWOT Analysis, 2015 156
Table 98: ArjoHuntleigh Company Profile 157
Table 99: ArjoHuntleigh SWOT Analysis, 2015 158
Table 100: DJO Global Company Profile 159
Table 101: DJO Global SWOT Analysis, 2015 159
Table 102: Lohmann & Rauscher Company Profile 160
Table 103: Lohmann & Rauscher SWOT Analysis, 2015 161
Table 104: Venosan (Salzmann) Company Profile 161
Table 105: Venosan (Salzmann) SWOT Analysis, 2015 162
Table 106: Sanyleg (Mimosa) Company Profile 163
Table 107: Sanyleg (Mimosa) SWOT Analysis, 2015 163
Table 108: Juzo Company Profile 164
Table 109: Juzo SWOT Analysis, 2015 164
Table 110: Daesung Maref Company Profile 165
Table 111: Daesung Maref SWOT Analysis, 2015 165
Table 112: Bio Compression Systems Company Profile 166
Table 113: Bio Compression Systems SWOT Analysis, 2015 166
Table 114: Smith & Nephew Company Profile 167
Table 115: Smith & Nephew SWOT Analysis, 2015 168
Table 116: Molnlycke Company Profile 169
Table 117: Molnlycke SWOT Analysis, 2015 170
Table 118: Gloria Med Company Profile 170
Table 119: Gloria Med SWOT Analysis, 2015 171
Table 120: B. Braun Company Profile 172
Table 121: B. Braun SWOT Analysis, 2015 173
Table 122: Alcare Company Profile 174
Table 123: Alcare SWOT Analysis, 2015 174
Table 124: Derma Sciences Company Profile 175
Table 125: Derma Sciences SWOT Analysis, 2015 176
Table 126: Laboratoires Urgo Company Profile 177
Table 127: Laboratoires Urgo SWOT Analysis, 2015 177
Table 128: Systagenix Company Profile 178
Table 129: Systagenix SWOT Analysis, 2015 179
Table 130: Muranaka Medical Instruments Company Profile 179
Table 131: Muranaka Medical Instruments SWOT Analysis, 2015 180
Table 132: ConvaTec Company Profile 181
Table 133: ConvaTec SWOT Analysis, 2015 182
Table 134: Xiamen Senyang Company Profile 182
Table 135: Xiamen Senyang SWOT Analysis, 2015 183
Table 136: Guangzhou Yihao Electronic Technology Company Profile 183
Table 137: Guangzhou Yihao SWOT Analysis, 2015 184
Table 138: Talley Group Company Profile 184
Table 139: Talley Group SWOT Analysis, 2015 185
Table 140: Cardinal Health Company Profile 185
Table 141: Cardinal Health SWOT Analysis, 2015 186
Table 142: Tactile Medical Company Profile 187
Table 143: Tactile Medical SWOT Analysis, 2015 187
Table 144: Devon Medical Company Profile 188
Table 145: Devon Medical SWOT Analysis, 2015 188
Table 146: Other Current Players 189
Table 147: Global Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 198
Table 148: Global Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 199
Table 149: EU5 Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 200
Table 150: APAC Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 201
Table 151: Compression Therapy Global Market Value Forecast by Country, $m, 2011–2021 204
Table 152: US Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 209
Table 153: US Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 211
Table 154: France Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 213
Table 155: France Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 214
Table 156: Germany Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 215
Table 157: Germany Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 217
Table 158: Italy Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 218
Table 159: Italy Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 220
Table 160: Spain Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 221
Table 161: Spain Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 222
Table 162: UK Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 223
Table 163: UK Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 224
Table 164: Japan Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 225
Table 165: Japan Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 227
Table 166: China Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 228
Table 167: China Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 230
Table 168: India Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 231
Table 169: India Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 232
Table 170: Brazil Market Value Forecast by Market Segment for Compression Therapy, $m, 2011–2021 233
Table 171: Brazil Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011–2021 235

1.2 List of Figures
Figure 1: Virchow’s Triad 26
Figure 2: US Company Market Shares for Static Compression Therapy, 2014 191
Figure 3: US Company Market Shares for Pneumatic Compression Therapy, 2014 192
Figure 4: 5EU Company Market Shares for Static Compression Therapy, 2014 193
Figure 5: 5EU Company Market Shares for Pneumatic Compression Therapy, 2014 194
Figure 6: APAC Company Market Shares for Static Compression Therapy, 2014 195
Figure 7: Brazil Company Market Shares for Static Compression Therapy, 2014 196
Figure 8: Global Market Value Forecast by Market Segment for Compression Therapy, 2011-2021 197
Figure 9: Global Market Value Forecast by Market Segment for Static Compression Therapy, 2011-2021 198
Figure 10: 5EU Market Value Forecast by Market Segment for Compression Therapy, 2011-2021 200
Figure 11: APAC Market Value Forecast by Market Segment for Compression Therapy, 2011-2021 201
Figure 12: Compression Therapy Global Market Value Forecast by Country, $m, 2011-2021 203
Figure 13: Compression Therapy Global Market Share Comparison by Country, 2014 and 2021 205
Figure 14: Global Pneumatic Compression Therapy Market Share Comparison by Country, 2014 and 2021 206
Figure 15: 5EU Compression Therapy Market Share Comparison by Country, 2014 and 2021 207
Figure 16: APAC Compression Therapy Market Share Comparison by Country, 2014 and 2021 208
Figure 17: US Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 209
Figure 18: US Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 211
Figure 19: France Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 212
Figure 20: France Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 214
Figure 21: Germany Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 215
Figure 22: Germany Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 216
Figure 23: Italy Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 218
Figure 24: Italy Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 219
Figure 25: Spain Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 220
Figure 26: Spain Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 221
Figure 27: UK Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 222
Figure 28: UK Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 224
Figure 29: Japan Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 225
Figure 30: Japan Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 227
Figure 31: China Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 228
Figure 32: China Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 229
Figure 33: India Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 230
Figure 34: India Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 232
Figure 35: Brazil Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021 233
Figure 36: Brazil Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021 234
Figure 37: Primary Research Participants By Country 276

【掲載企業】

Covidien (Medtronic)
Sigvaris
BSN Medical
Medi
Innothera
3M Health Care
Thuasne
Paul Hartmann
Mego Afek
Medline Industries
ArjoHuntleigh (Getinge)
DJO Global
Lohmann & Rauscher
Venosan (Salzmann)
Sanyleg (Mimosa)
Juzo
Daesung Maref
Bio Compression Systems
Smith & Nephew
Molnlycke Health Care
Gloria Med
B. Braun
Alcare
Derma Sciences
Laboratoires Urgo
Systagenix (Acelity)
Muranaka Medical Instruments
ConvaTec
Xiamen Senyang
Guangzhou Yihao Electronic Technology
Talley Group
Cardinal Health
Tactile Medical
Devon Medical

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[圧迫療法の世界市場分析および予測]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年08月25日現在 202,314 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆